UROMITEXAN 400 MG Израиль - английский - Ministry of Health

uromitexan 400 mg

megapharm ltd - mesna - solution for injection - mesna 400 mg/vial - mesna - prevention of urinary passage toxicity of oxazaphosphorines (ifosfamide ,cyclophosphamide, trofosamide), in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, cyclophosphamide or trofosamide , urinary passage diseases in anamnesis.

FOSFA 2gm with Mesna Injection 200mg/2ml Powder For Injection Кения - английский - Pharmacy and Poisons Board

fosfa 2gm with mesna injection 200mg/2ml powder for injection

getwell pharmaceuticals ltd 474, udyog vihar, phase-v, gurugram- 122016, - ifosfamide usp and mesna bp - powder for injection - 2gm of sterile ifosfamide usp and mesna bp… - combinations of antineoplastic agents

Uromitexan 100mg/ml Solution for Injection or Infusion Ирландия - английский - HPRA (Health Products Regulatory Authority)

uromitexan 100mg/ml solution for injection or infusion

baxter holding b.v. - mesna - solution for injection/infusion - 100 milligram(s)/millilitre - detoxifying agents for antineoplastic treatment; mesna

Uromitexan Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

uromitexan

baxter healthcare ltd - mesna 100 mg/ml;   - solution for injection - 100 mg/ml - active: mesna 100 mg/ml   excipient: disodium edetate dihydrate sodium hydroxide water for injection - for the prophylaxis of haematuria and haemorrhagic cystitis in patients treated with cyclophosphamide or ifosfamide in doses considered to be urotoxic. uromitexan is also indicated in at risk patients even though these patients may be receiving relatively low doses of oxazaphosphorines. at risk patients include those that have experienced previous irradiation of the small pelvis, cystitis with earlier oxazaphosphorine therapy, and/or a case history of urinary tract disease.

Uromitexan Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

uromitexan

baxter healthcare ltd - mesna 600mg - film coated tablet - 600 mg - active: mesna 600mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).

Uromitexan Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

uromitexan

baxter healthcare ltd - mesna 400mg - tablet - 400 mg - active: mesna 400mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).